Skip to main content

Featured

8.92m vaccine doses administered

About 8,923,300 doses of COVID-19 vaccines have been administered to the public, with about 4,570,000 people receiving their first dose and around 4,353,200 getting their second dose.   Among those given the first dose of vaccines, about 1,660,600 people have received the Sinovac jab and about 2,909,500 people got the BioNTech one.   For the second dose, about 1,587,200 people have received the Sinovac vaccine, while about 2,766,000 people have been administered the BioNTech jab.   About 9,300 people received jabs under the COVID-19 Vaccination Programme today.   Around 1,800 people received their first dose of the Sinovac vaccine and around 2,600 people received their second dose.   For the BioNTech vaccine, about 2,300 people received their first dose and around 2,800 people got their second dose.   The overall percentage of people who received the Sinovac vaccine at community vaccination centres is about 97%, while it is about 90% for the BioNTech one. http://dlvr.it/S9t

COVID-19 case explained

The Food & Health Bureau today said it is not unusual in the field of molecular biological testing that virus test results may not be consistently reproducible when a patient is tested repeatedly.   It was responding to media reports about case number 9741 which was confirmed on January 20, and previously underwent COVID-19 testing and received a negative result.   The bureau, having engaged Prof Yuen Kwok-yung, a member of the Expert Advisory Panel and his team at the University of Hong Kong to conduct a review and analysis, announced the results yesterday.   The case number 9741 patient consulted a private doctor on January 13. He had developed symptoms at that time but did not undergo testing.   He went to the community testing centre at Henry G. Leong Yaumatei Community Centre on January 15 and the mobile specimen collection station on Canton Road on January 18 for virus tests. Both returned negative results.   The patient later felt unwell and was sent to hospital on January 18. After admission, the hospital took his nasopharyngeal aspirate and throat swab for testing and he was subsequently confirmed positive.   The analysis found that the patient had a low viral load (Ct value of 33) and the serum antibody test came back positive on January 20, indicating a low risk of spreading the virus.   The upper respiratory tract specimens previously collected from the patient at the community testing centre and mobile specimen collection station showed a viral reaction after re-examination, but the viral load was extremely low (Ct value 39), which exceeded the limit that the common nucleic acid tests can accurately and consistently detect as positive reactions.   Experts estimated that the patient only received sampling for testing many days after the onset of the disease, adding that it would be better if the patient in this case had been tested at the first medical consultation.
http://dlvr.it/RrJQf5

Popular Posts